Global Vaccines Market Growth 2021-2026

  • receipt Report ID : 261091
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Vaccines will have significant change from previous year. By the most conservative estimates of global Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 41150 million in 2020. Over the next five years the Vaccines market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 51580 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Recombinant Vaccines

Viral Vaccines

Polysaccharide Vaccines

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Cholera

Hepatitis B

Diphtheria

Tetanus

Measles Vaccine

Hepatitis A

Live Attenuated Influenza Vaccine

Polio Vaccine

Rabies Vaccine

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

GSK

Sanofi

Merck

Pfizer

Novartis(GSK)

CSL

MedImmune LLC

J&J(Crucell)

China National Biotec

Tiantan

Hualan

Kangtai

Hissen

Jintan

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaccines Consumption 2016-2026

2.1.2 Vaccines Consumption CAGR by Region

2.2 Vaccines Segment by Type

2.2.1 Recombinant Vaccines

2.2.2 Viral Vaccines

2.2.3 Polysaccharide Vaccines

2.2.4 Others

2.3 Vaccines Sales by Type

2.3.1 Global Vaccines Sales Market Share by Type (2016-2021)

2.3.2 Global Vaccines Revenue and Market Share by Type (2016-2021)

2.3.3 Global Vaccines Sale Price by Type (2016-2021)

2.4 Vaccines Segment by Application

2.4.1 Cholera

2.4.2 Hepatitis B

2.4.3 Diphtheria

2.4.4 Tetanus

2.4.5 Measles Vaccine

2.4.6 Hepatitis A

2.4.7 Live Attenuated Influenza Vaccine

2.4.8 Polio Vaccine

2.4.9 Rabies Vaccine

2.5 Vaccines Sales by Application

2.5.1 Global Vaccines Sale Market Share by Application (2016-2021)

2.5.2 Global Vaccines Revenue and Market Share by Application (2016-2021)

2.5.3 Global Vaccines Sale Price by Application (2016-2021)

3 Global Vaccines by Company

3.1 Global Vaccines Sales Market Share by Company

3.1.1 Global Vaccines Sales by Company (2019-2021)

3.1.2 Global Vaccines Sales Market Share by Company (2019-2021)

3.2 Global Vaccines Revenue Market Share by Company

3.2.1 Global Vaccines Revenue by Company (2019-2021)

3.2.2 Global Vaccines Revenue Market Share by Company (2019-2021)

3.3 Global Vaccines Sale Price by Company

3.4 Global Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaccines Product Location Distribution

3.4.2 Players Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Vaccines by Region

4.1 Global Vaccines by Region

4.1.1 Global Vaccines Sales by Region

4.1.2 Global Vaccines Revenue by Region

4.2 Americas Vaccines Sales Growth

4.3 APAC Vaccines Sales Growth

4.4 Europe Vaccines Sales Growth

4.5 Middle East & Africa Vaccines Sales Growth

5 Americas

5.1 Americas Vaccines Sales by Country

5.1.1 Americas Vaccines Sales by Country (2016-2021)

5.1.2 Americas Vaccines Revenue by Country (2016-2021)

5.2 Americas Vaccines Sales by Type

5.3 Americas Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaccines Sales by Region

6.1.1 APAC Vaccines Sales by Region (2016-2021)

6.1.2 APAC Vaccines Revenue by Region (2016-2021)

6.2 APAC Vaccines Sales by Type

6.3 APAC Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Vaccines by Country

7.1.1 Europe Vaccines Sales by Country (2016-2021)

7.1.2 Europe Vaccines Revenue by Country (2016-2021)

7.2 Europe Vaccines Sales by Type

7.3 Europe Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaccines by Country

8.1.1 Middle East & Africa Vaccines Sales by Country (2016-2021)

8.1.2 Middle East & Africa Vaccines Revenue by Country (2016-2021)

8.2 Middle East & Africa Vaccines Sales by Type

8.3 Middle East & Africa Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Vaccines Distributors

10.3 Vaccines Customer

11 Global Vaccines Market Forecast

11.1 Global Vaccines Forecast by Region

11.1.1 Global Vaccines Forecast by Regions (2021-2026)

11.2.2 Global Vaccines Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Vaccines Forecast by Type

11.7 Global Vaccines Forecast by Application

12 Key Players Analysis

12.1 GSK

12.1.1 GSK Company Information

12.1.2 GSK Vaccines Product Offered

12.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 GSK Main Business Overview

12.1.5 GSK Latest Developments

12.2 Sanofi

12.2.1 Sanofi Company Information

12.2.2 Sanofi Vaccines Product Offered

12.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Sanofi Main Business Overview

12.2.5 Sanofi Latest Developments

12.3 Merck

12.3.1 Merck Company Information

12.3.2 Merck Vaccines Product Offered

12.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Merck Main Business Overview

12.3.5 Merck Latest Developments

12.4 Pfizer

12.4.1 Pfizer Company Information

12.4.2 Pfizer Vaccines Product Offered

12.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Pfizer Main Business Overview

12.4.5 Pfizer Latest Developments

12.5 Novartis(GSK)

12.5.1 Novartis(GSK) Company Information

12.5.2 Novartis(GSK) Vaccines Product Offered

12.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Novartis(GSK) Main Business Overview

12.5.5 Novartis(GSK) Latest Developments

12.6 CSL

12.6.1 CSL Company Information

12.6.2 CSL Vaccines Product Offered

12.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 CSL Main Business Overview

12.6.5 CSL Latest Developments

12.7 MedImmune LLC

12.7.1 MedImmune LLC Company Information

12.7.2 MedImmune LLC Vaccines Product Offered

12.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 MedImmune LLC Main Business Overview

12.7.5 MedImmune LLC Latest Developments

12.8 J&J(Crucell)

12.8.1 J&J(Crucell) Company Information

12.8.2 J&J(Crucell) Vaccines Product Offered

12.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 J&J(Crucell) Main Business Overview

12.8.5 J&J(Crucell) Latest Developments

12.9 China National Biotec

12.9.1 China National Biotec Company Information

12.9.2 China National Biotec Vaccines Product Offered

12.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 China National Biotec Main Business Overview

12.9.5 China National Biotec Latest Developments

12.10 Tiantan

12.10.1 Tiantan Company Information

12.10.2 Tiantan Vaccines Product Offered

12.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Tiantan Main Business Overview

12.10.5 Tiantan Latest Developments

12.11 Hualan

12.11.1 Hualan Company Information

12.11.2 Hualan Vaccines Product Offered

12.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Hualan Main Business Overview

12.11.5 Hualan Latest Developments

12.12 Kangtai

12.12.1 Kangtai Company Information

12.12.2 Kangtai Vaccines Product Offered

12.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Kangtai Main Business Overview

12.12.5 Kangtai Latest Developments

12.13 Hissen

12.13.1 Hissen Company Information

12.13.2 Hissen Vaccines Product Offered

12.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Hissen Main Business Overview

12.13.5 Hissen Latest Developments

12.14 Jintan

12.14.1 Jintan Company Information

12.14.2 Jintan Vaccines Product Offered

12.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Jintan Main Business Overview

12.14.5 Jintan Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Vaccines Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Recombinant Vaccines

Table 3. Major Players of Viral Vaccines

Table 4. Major Players of Polysaccharide Vaccines

Table 5. Major Players of Others

Table 6. Global Vaccines Sales by Type (2016-2021) & (K Pcs)

Table 7. Global Vaccines Sales Market Share by Type (2016-2021)

Table 8. Global Vaccines Revenue by Type (2016-2021) & ($ million)

Table 9. Global Vaccines Revenue Market Share by Type (2016-2021)

Table 10. Global Vaccines Sale Price by Type (2016-2021)

Table 11. Global Vaccines Sales by Application (2016-2021) & (K Pcs)

Table 12. Global Vaccines Sales Market Share by Application (2016-2021)

Table 13. Global Vaccines Value by Application (2016-2021)

Table 14. Global Vaccines Revenue Market Share by Application (2016-2021)

Table 15. Global Vaccines Sale Price by Application (2016-2021)

Table 16. Global Vaccines Sales by Company (2019-2021) & (K Pcs)

Table 17. Global Vaccines Sales Market Share by Company (2019-2021)

Table 18. Global Vaccines Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Vaccines Revenue Market Share by Company (2019-2021)

Table 20. Global Vaccines Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Vaccines Producing Area Distribution and Sales Area

Table 22. Players Vaccines Products Offered

Table 23. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Vaccines Sales by Region (2016-2021) (K Pcs)

Table 27. Global Vaccines Sales Market Share by Region (2016-2021)

Table 28. Global Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Vaccines Revenue Market Share by Region (2016-2021)

Table 30. Americas Vaccines Sales by Country (2016-2021) & (K Pcs)

Table 31. Americas Vaccines Sales Market Share by Country (2016-2021)

Table 32. Americas Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Vaccines Revenue Market Share by Country (2016-2021)

Table 34. Americas Vaccines Sales by Type (2016-2021) & (K Pcs)

Table 35. Americas Vaccines Sales Market Share by Type (2016-2021)

Table 36. Americas Vaccines Sales by Application (2016-2021) & (K Pcs)

Table 37. Americas Vaccines Sales Market Share by Application (2016-2021)

Table 38. APAC Vaccines Sales by Region (2016-2021) & (K Pcs)

Table 39. APAC Vaccines Sales Market Share by Region (2016-2021)

Table 40. APAC Vaccines Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Vaccines Revenue Market Share by Region (2016-2021)

Table 42. APAC Vaccines Sales by Type (2016-2021) & (K Pcs)

Table 43. APAC Vaccines Sales Market Share by Type (2016-2021)

Table 44. APAC Vaccines Sales by Application (2016-2021) & (K Pcs)

Table 45. APAC Vaccines Sales Market Share by Application (2016-2021)

Table 46. Europe Vaccines Sales by Country (2016-2021) & (K Pcs)

Table 47. Europe Vaccines Sales Market Share by Country (2016-2021)

Table 48. Europe Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Vaccines Revenue Market Share by Country (2016-2021)

Table 50. Europe Vaccines Sales by Type (2016-2021) & (K Pcs)

Table 51. Europe Vaccines Sales Market Share by Type (2016-2021)

Table 52. Europe Vaccines Sales by Application (2016-2021) & (K Pcs)

Table 53. Europe Vaccines Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Vaccines Sales by Country (2016-2021) & (K Pcs)

Table 55. Middle East & Africa Vaccines Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Vaccines Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Vaccines Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Vaccines Sales by Type (2016-2021) & (K Pcs)

Table 59. Middle East & Africa Vaccines Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Vaccines Sales by Application (2016-2021) & (K Pcs)

Table 61. Middle East & Africa Vaccines Sales Market Share by Application (2016-2021)

Table 62. Key and Potential Regions of Vaccines

Table 63. Key Application and Potential Industries of Vaccines

Table 64. Key Challenges of Vaccines

Table 65. Key Trends of Vaccines

Table 66. Vaccines Distributors List

Table 67. Vaccines Customer List

Table 68. Global Vaccines Sales Forecast by Region (2021-2026) & (K Pcs)

Table 69. Global Vaccines Consumption Market Forecast by Region

Table 70. Global Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)

Table 71. Global Vaccines Revenue Market Share Forecast by Region (2021-2026)

Table 72. Americas Vaccines Sales Forecast by Country (2021-2026) & (K Pcs)

Table 73. Americas Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)

Table 74. APAC Vaccines Sales Forecast by Region (2021-2026) & (K Pcs)

Table 75. APAC Vaccines Revenue Forecast by Region (2021-2026) & ($ millions)

Table 76. Europe Vaccines Sales Forecast by Country (2021-2026) & (K Pcs)

Table 77. Europe Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)

Table 78. Middle East & Africa Vaccines Sales Forecast by Country (2021-2026) & (K Pcs)

Table 79. Middle East & Africa Vaccines Revenue Forecast by Country (2021-2026) & ($ millions)

Table 80. Global Vaccines Sales Forecast by Type (2021-2026) & (K Pcs)

Table 81. Global Vaccines Sales Market Share Forecast by Type (2021-2026)

Table 82. Global Vaccines Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 83. Global Vaccines Revenue Market Share Forecast by Type (2021-2026)

Table 84. Global Vaccines Sales Forecast by Application (2021-2026) & (K Pcs)

Table 85. Global Vaccines Sales Market Share Forecast by Application (2021-2026)

Table 86. Global Vaccines Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 87. Global Vaccines Revenue Market Share Forecast by Application (2021-2026)

Table 88. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 89. GSK Vaccines Product Offered

Table 90. GSK Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 91. GSK Main Business

Table 92. GSK Latest Developments

Table 93. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Sanofi Vaccines Product Offered

Table 95. Sanofi Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 96. Sanofi Main Business

Table 97. Sanofi Latest Developments

Table 98. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Merck Vaccines Product Offered

Table 100. Merck Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 101. Merck Main Business

Table 102. Merck Latest Developments

Table 103. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Vaccines Product Offered

Table 105. Pfizer Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 106. Pfizer Main Business

Table 107. Pfizer Latest Developments

Table 108. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Novartis(GSK) Vaccines Product Offered

Table 110. Novartis(GSK) Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 111. Novartis(GSK) Main Business

Table 112. Novartis(GSK) Latest Developments

Table 113. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. CSL Vaccines Product Offered

Table 115. CSL Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 116. CSL Main Business

Table 117. CSL Latest Developments

Table 118. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. MedImmune LLC Vaccines Product Offered

Table 120. MedImmune LLC Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 121. MedImmune LLC Main Business

Table 122. MedImmune LLC Latest Developments

Table 123. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. J&J(Crucell) Vaccines Product Offered

Table 125. J&J(Crucell) Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 126. J&J(Crucell) Main Business

Table 127. J&J(Crucell) Latest Developments

Table 128. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. China National Biotec Vaccines Product Offered

Table 130. China National Biotec Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 131. China National Biotec Main Business

Table 132. China National Biotec Latest Developments

Table 133. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Tiantan Vaccines Product Offered

Table 135. Tiantan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 136. Tiantan Main Business

Table 137. Tiantan Latest Developments

Table 138. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 139. Hualan Vaccines Product Offered

Table 140. Hualan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 141. Hualan Main Business

Table 142. Hualan Latest Developments

Table 143. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 144. Kangtai Vaccines Product Offered

Table 145. Kangtai Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 146. Kangtai Main Business

Table 147. Kangtai Latest Developments

Table 148. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 149. Hissen Vaccines Product Offered

Table 150. Hissen Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 151. Hissen Main Business

Table 152. Hissen Latest Developments

Table 153. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 154. Jintan Vaccines Product Offered

Table 155. Jintan Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2019-2021E)

Table 156. Jintan Main Business

Table 157. Jintan Latest Developments

List of Figures

Figure 1. Picture of Vaccines

Figure 2. Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaccines Sales Growth Rate 2016-2026 (K Pcs)

Figure 7. Global Vaccines Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Vaccines Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Recombinant Vaccines

Figure 10. Product Picture of Viral Vaccines

Figure 11. Product Picture of Polysaccharide Vaccines

Figure 12. Product Picture of Others

Figure 13. Global Vaccines Sales Market Share by Type in 2020

Figure 14. Global Vaccines Revenue Market Share by Type (2016-2021)

Figure 15. Vaccines Consumed in Cholera

Figure 16. Global Vaccines Market: Cholera (2016-2021) & (K Pcs)

Figure 17. Vaccines Consumed in Hepatitis B

Figure 18. Global Vaccines Market: Hepatitis B (2016-2021) & (K Pcs)

Figure 19. Vaccines Consumed in Diphtheria

Figure 20. Global Vaccines Market: Diphtheria (2016-2021) & (K Pcs)

Figure 21. Vaccines Consumed in Tetanus

Figure 22. Global Vaccines Market: Tetanus (2016-2021) & (K Pcs)

Figure 23. Vaccines Consumed in Measles Vaccine

Figure 24. Global Vaccines Market: Measles Vaccine (2016-2021) & (K Pcs)

Figure 25. Vaccines Consumed in Hepatitis A

Figure 26. Global Vaccines Market: Hepatitis A (2016-2021) & (K Pcs)

Figure 27. Vaccines Consumed in Live Attenuated Influenza Vaccine

Figure 28. Global Vaccines Market: Live Attenuated Influenza Vaccine (2016-2021) & (K Pcs)

Figure 29. Vaccines Consumed in Polio Vaccine

Figure 30. Global Vaccines Market: Polio Vaccine (2016-2021) & (K Pcs)

Figure 31. Vaccines Consumed in Rabies Vaccine

Figure 32. Global Vaccines Market: Rabies Vaccine (2016-2021) & (K Pcs)

Figure 33. Global Vaccines Sales Market Share by Application (2016-2021)

Figure 34. Global Vaccines Revenue Market Share by Application in 2020

Figure 35. Vaccines Revenue Market by Company in 2020 ($ Million)

Figure 36. Global Vaccines Revenue Market Share by Company in 2020

Figure 37. Global Vaccines Sales Market Share by Regions (2016-2021)

Figure 38. Global Vaccines Revenue Market Share by Region in 2020

Figure 39. Americas Vaccines Sales 2016-2021 (K Pcs)

Figure 40. Americas Vaccines Revenue 2016-2021 ($ Millions)

Figure 41. APAC Vaccines Sales 2016-2021 (K Pcs)

Figure 42. APAC Vaccines Revenue 2016-2021 ($ Millions)

Figure 43. Europe Vaccines Sales 2016-2021 (K Pcs)

Figure 44. Europe Vaccines Revenue 2016-2021 ($ Millions)

Figure 45. Middle East & Africa Vaccines Sales 2016-2021 (K Pcs)

Figure 46. Middle East & Africa Vaccines Revenue 2016-2021 ($ Millions)

Figure 47. Americas Vaccines Sales Market Share by Country in 2020

Figure 48. Americas Vaccines Revenue Market Share by Country in 2020

Figure 49. Americas Vaccines Sales Market Share by Type in 2020

Figure 50. Americas Vaccines Sales Market Share by Application in 2020

Figure 51. United States Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 52. Canada Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 53. Mexico Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 54. Brazil Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 55. APAC Vaccines Sales Market Share by Region in 2020

Figure 56. APAC Vaccines Revenue Market Share by Regions in 2020

Figure 57. APAC Vaccines Sales Market Share by Type in 2020

Figure 58. APAC Vaccines Sales Market Share by Application in 2020

Figure 59. China Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 60. Japan Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 61. Korea Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 62. Southeast Asia Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 63. India Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 64. Australia Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 65. Europe Vaccines Sales Market Share by Country in 2020

Figure 66. Europe Vaccines Revenue Market Share by Country in 2020

Figure 67. Europe Vaccines Sales Market Share by Type in 2020

Figure 68. Europe Vaccines Sales Market Share by Application in 2020

Figure 69. Germany Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 70. France Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 71. UK Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 72. Italy Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 73. Russia Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 74. Middle East & Africa Vaccines Sales Market Share by Country in 2020

Figure 75. Middle East & Africa Vaccines Revenue Market Share by Country in 2020

Figure 76. Middle East & Africa Vaccines Sales Market Share by Type in 2020

Figure 77. Middle East & Africa Vaccines Sales Market Share by Application in 2020

Figure 78. Egypt Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 79. South Africa Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 80. Israel Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 81. Turkey Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 82. GCC Country Vaccines Revenue Growth 2016-2021 ($ Millions)

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Please fill the form below, to recieve the report sample


+1